A number of other equities analysts also recently commented on MOH. Piper Jaffray Companies raised their target price on shares of Molina Healthcare to $165.00 and gave the company an overweight rating in a research note on Wednesday, September 26th. Zacks Investment Research downgraded shares of Molina Healthcare from a buy rating to a hold rating in a research note on Monday, October 8th. Evercore ISI began coverage on shares of Molina Healthcare in a research note on Tuesday, October 9th. They issued an in-line rating and a $158.00 target price on the stock. Jefferies Financial Group downgraded shares of Molina Healthcare from a buy rating to a hold rating and set a $152.00 target price on the stock. in a research note on Friday, October 12th. They noted that the move was a valuation call. Finally, Barclays raised their target price on shares of Molina Healthcare from $105.00 to $125.00 and gave the company an equal weight rating in a research note on Thursday, August 2nd. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and six have assigned a buy rating to the company. The stock presently has an average rating of Hold and a consensus price target of $129.77.
Shares of MOH traded down $7.46 during mid-day trading on Thursday, reaching $134.94. The company had a trading volume of 25,957 shares, compared to its average volume of 1,014,573. The firm has a market cap of $8.84 billion, a PE ratio of 252.71, a price-to-earnings-growth ratio of 1.65 and a beta of 1.27. Molina Healthcare has a fifty-two week low of $62.08 and a fifty-two week high of $154.06. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.73.
In related news, insider Norman Nichols sold 4,501 shares of Molina Healthcare stock in a transaction on Wednesday, August 8th. The shares were sold at an average price of $127.00, for a total transaction of $571,627.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Ronna Romney sold 200 shares of Molina Healthcare stock in a transaction on Tuesday, September 4th. The stock was sold at an average price of $138.11, for a total transaction of $27,622.00. The disclosure for this sale can be found here. Insiders have sold a total of 9,717 shares of company stock worth $1,289,932 in the last ninety days. 0.65% of the stock is currently owned by insiders.
Institutional investors have recently added to or reduced their stakes in the stock. Advisors Asset Management Inc. raised its holdings in shares of Molina Healthcare by 2,264.2% in the 2nd quarter. Advisors Asset Management Inc. now owns 93,813 shares of the company’s stock worth $118,000 after purchasing an additional 89,845 shares in the last quarter. Integrated Investment Consultants LLC acquired a new stake in shares of Molina Healthcare during the second quarter valued at approximately $165,000. Contravisory Investment Management Inc. acquired a new stake in shares of Molina Healthcare during the second quarter valued at approximately $166,000. Zeke Capital Advisors LLC acquired a new stake in shares of Molina Healthcare during the second quarter valued at approximately $206,000. Finally, CIBC Asset Management Inc acquired a new stake in shares of Molina Healthcare during the second quarter valued at approximately $211,000.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Further Reading: Buyback For Investors Defined
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.